跳到正文
原文
Nature Medicine· Jochen Wilhelm·· 10 天前AI 评分60

血液 RNA 生物标志物用于早期检测卵巢癌

Blood-based RNA biomarker for the early detection of ovarian cancer

AI 导读

研究团队开发了一种基于血液的 RNA 生物标志物 Tu-stroma,用于早期检测卵巢癌,在 506 例个体中表现出色,优于 CA125。

正文

Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04732-9

Tested in a cohort of 506 individuals, the RNA-based biomarker of microenvironment fitness Tu-stroma shows high performance in discriminating early-stage ovarian cancer from benign lesions, outperforming CA125.

来源:Nature Medicine · nature.com